Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment

Breast cancer therapies using checkpoints alone have not been highly effective. Based on previous experiences using the ConvitVax, an autologous tumor cells/bacillus Calmette-Guérin (BCG)/formalin-based vaccine, in breast cancer and the potential success of combined therapies, we sought to ascertain...

Descripción completa

Detalles Bibliográficos
Autores principales: Godoy-Calderón, María José, González-Marcano, Eglys, Carballo, Jeismar, Convit, Ana Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859918/
https://www.ncbi.nlm.nih.gov/pubmed/31762937
http://dx.doi.org/10.18632/oncotarget.27283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859918/
https://www.ncbi.nlm.nih.gov/pubmed/31762937
http://dx.doi.org/10.18632/oncotarget.27283

Ejemplares similares